Genetic approaches in the clinical investigation of complex disorders: Malnutrition, inflammation, and atherosclerosis (MIA) as a prototype

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Pecoits Filho, Roberto ^b   Nordfors, Louise ^b   Lindholm, Bengt ^b   Hoff, Catherine M ^b   Schalling, Martin ^b   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Atherosclerosis; ESRD; Inflammation; Malnutrition; Single neucleotide polymorphisms

Indexed keywords

ATHEROSCLEROSIS; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC DIFFERENCE; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; INFLAMMATION; KIDNEY FAILURE; MALNUTRITION; MOLECULAR GENETICS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYNDROME; ARTERIOSCLEROSIS; CHRONIC KIDNEY FAILURE; GENETIC LINKAGE; GENETICS; IMMUNOLOGY; NUTRITIONAL DISORDER; REVIEW;

ARTERIOSCLEROSIS; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); NUTRITION DISORDERS;

EID: 0242500831     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.39.x     Document Type: Conference Paper

References (41)

1. IYENGAR SK, SCHELLING JR, SEDOR JR: Approaches to understanding susceptibility to nephropathy: From genetics to genomics. Kidney Int 61(Suppl 1):61-67, 2002
2. STENVINKEL P, HEIMBÜRGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
3. VENTER JC, ADAMS MD, MYERS EW, et al: The sequence of the human genome. Science 291:1304-1351, 2001
4. LANDER ES, LINTON LM, BIRREN B, et al: Initial sequencing and analysis of the human genome. Nature 409:860-921, 2001
5. SACHIDANANDAM R, WEISSMAN D, SCHMIDT SC, et al: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933, 2001
6. NORDFORS L, JANSSON M, SANDBERG G, et al: Large-scale genotyping of single nucleotide polymorphisms by pyrosequencing and validation against the 5′nuclease (Taqman) assay. Hum Mutat 19:395-401, 2002
7. STENVINKEL P, HEIMBÜRGER O, LINDHOLM B, et al: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953-960, 2000
8. BERGSTRÖM J, LINDHOLM B: Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 32:834-841, 1998
9. HEIMBÜRGER O, LONNQVIST F, DANIELSSON A, et al: Serum immuno-reactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8:1423-1430, 1997
10. OHSHIRO Y, UEDA K, NISHI M, et al: A polymorphic marker in the leptin gene associated with Japanese morbid obesity. J Mol Med 78:516-520, 2000
11. ZOCCALI C, MALLAMACI F, TRIPEPI G, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 13:134-141, 2002
12. HARA K, BOUTIN P, MORI Y, et al: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540, 2002
13. ISEKI K, TOZAWA M, YOSHI S, et al: Serum C-reactive (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transpl 14:1956-1960, 1999
14. CAO H, HEGELE RA: Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 45:100-101, 2000
15. ZEE RY, RIDKER PM: Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162:217-219, 2002
16. KIMMEL PL, PHILLIPS TM, SIMMENS SJ, et al: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
17. MANZOLI A, ANDREOTTI F, VARLOTTA C, et al: Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease. Cardiologia 44:825-830, 1999
18. BERGER P, MCCONNELL JP, NUNN M, et al: C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 17:171-174, 2002
19. STENVINKEL P, BÁRÁNY P, HEIMBÜRGER O, et al: Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int 61(Suppl 80):103-108, 2002
20. PECOITS-FILHO R, BÁRÁNY P, LINDHOLM B, et al: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:142-146, 2002
21. BRULL DJ, MONTGOMERY HE, SANDERS J, et al: Interleukin-6 gene-174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21:1458-1463, 2001
22. PINDERSKI LJ, FISCHBEIN MP, SUBBANAGOUNDER G, et al: Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res 90:1064-1071, 2002
23. WESTENDORP RG, LANGERMANS JA, HUIZINGA TW, et al: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-173, 1997
24. LAZARUS M, HAJEER AH, TURNER D, et al: Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314-2317, 1997
25. TAGORE A, GONSALKORALE WM, PRAVICA V, et al: Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 54:386-390, 1999
26. GIRNDT M, KAUL H, SESTER U, et al: Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949-955, 2002
27. KOCH W, KASTRATI A, BOTTIGER C, et al: Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159:137-144, 2001
28. STENVINKEL P, LINDHOLM B, HEIMBÜRGER M, et al: Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15:1624-1630, 2000
29. MCLAREN AJ, MARSHALL SE, HALDAR NA, et al: Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 55:1977-1982, 1999
30. ILVESKOSKI E, PEROLA M, LEHTIMAKI T, et al: Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: An autopsy study. Circulation 100:608-613, 1999
31. EGGERTSEN G, HEIMBÜRGER O, STENVINKEL P, et al: Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Nephrol Dial Transplant 12:141-144, 1997
32. GUZ G, NURHAN OZDEMIR F, SEZER S, et al: Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis 36:826-836, 2000
33. ROBINSON K, GUPTA A, DENNIS V, et al: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in endstage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743-2748, 1996
34. SULIMAN ME, QURESHI AR, BÁRÁNY P, et al: Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 57:1727-1735, 2000
35. WRONE EM, ZEHNDER JL, HORNBERGER JM, et al: An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int 60:1106-1113, 2001
36. STENVINKEL P, HEIMBÜRGER O, JOGESTRAND T, et al: Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? Kidney Int 55:2531-2532, 1999
37. KIECHL S, LORENZ E, REINDL M, et al: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192, 2002
38. HOY A, LEININGER-MULLER B, KUTTER D, et al: Growing significance of myeloperoxidase in non-infectious diseases. Clin Chem Lab Med 40:2-8, 2002
39. PIEDRAFITA FJ, MOLANDER RB, VANSANT G, et al: An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271:14412-14420, 1996
40. NIKPOOR B,TURECKI G, FOURNIER C, et al: A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 142:336-339, 2001
41. PECOITS-FILHO R, STENVINKEL P, MARCHLEWSKA A, et al: A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int, 2002